Issue of Options
Director Sofia Kolyda issued 358,772 options at 11 pence per share, expiring August 2035.
- Options issued 358,772
- Exercise price 11p per share
- Expiry date 6 August 2035
Select text to share a quote on X · sign in to keep highlights & notes in your OPTI notes
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare, announces that the Company has issued 358,772 options over new ordinary shares with an exercise price of 11 pence per share ("New Options") to Sofia Kolyda, a Director of the Company.
The New Options expire on 6 August 2035 with 269,079 of the New Options vesting on the first anniversary of the options being granted being 6 August 2026 and the balance (comprising 89,693 New Options) vesting once the Company signs a commercial agreement with a partner providing equal or greater than £100k revenues per annum for products containing SweetBiotix.
The issue of the New Options follows the expiration of 358,772 options of ordinary shares granted to Sofia Kolyda which expired in March 2025 of which 75% had vested.
| a. | Name | Sofia Kolyda |
| 2 | Reason for notification | |
| a. | Position/Status | Director |
| b. | Initial notification/ Amendment | Initial Notification |
| a. | Name | OptiBiotix Health Plc |
| b. | LEI | |
| a. | Description of the financial instrument, type of instrument Identification Code | Options over new ordinary shares of 2p each ISIN: GB00BP0RTP38 |
| b. | Nature of the transaction | Issue of options pursuant to the New Options |
| c. | Price(s) and volume(s) | |
| Price(s) per share | Volume(s) | |
| 11p | 358,772 | |
| d. | Aggregated information - Volume - Price | N/A |
| f. | Place of the transaction | London |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.